05.10.2021

Online Course "Innovations In Treatment And Management Of Drug-Resistant TB" By WHO CC Latvia

On September 20-22 and 27-28, 2021, the WHO CC for Research and Training in Management of MDR TB held an international online course "Innovations in treatment and management of drug-resistant TB”, which was attended by three specialists from the Arkhangelsk Oblast and one from the Komi Republic.

The course covered issues related to the tuberculosis action plan for the WHO European Region, the global strategy and goals for the prevention, treatment and control of TB, the epidemiology of TB, MDR/XDR-TB, TB-HIV globally and in the European region, the impact of the COVID-19 pandemic on TB control, medicines for the treatment of MDR-TB, adverse reactions, infection control and much more. The course received the highest rating based on the results of the WHO CC questionnaire.

In total, 25 specialists from Russia, Ukraine and Kyrgyzstan took part in the course. Participation in the course was done with the support of the International Tuberculosis Foundation LHL International.

Below are the feedback from the participants (their impressions of the course, the most relevant topics, thoughts and suggestions):

"The lecturers provided excellent material in a visual form with very detailed explanations".

"The experience of other countries in the diagnosis of tuberculosis, the treatment of MDR/XDR tuberculosis, the use of new anti-tuberculosis drugs, the effectiveness of the use of new drugs and short treatment regimens. Communication with doctors from different countries. Lively discussions".

"Not only theoretical material is presented, but also our own practical experience."

"It could be nice to have shorter (e.g. three hours a day) sessions, but an extended course (7-8 days)".

"I will discuss with my colleagues the challenges identified in our and neighboring regions and look for ways to address these challenges."

"The use of short courses of MDR/XDR tuberculosis treatment. Treatment regimen for H-resistant tuberculosis. Treatment of LTI. Patient-oriented approach in the diagnosis and treatment of tuberculosis. Diagnostics and treatment regimens of mycobacteriosis".

"More attention to adverse reactions. Communication skills training".

"Many thanks to all the organizers of the course "Innovations in the treatment and management of drug-resistant tuberculosis!!!" All reports were very informative, accessible and relevant."

"Thank you so much for the warm welcome!"

(reviews and photos courtesy of WHO CC Latvia)